Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Ligand Pharmaceuticals' key financial indicators are inconsi...

Ligand Pharmaceuticals' key financial indicators are inconsistent, raising questions about the sustainability of its current share price momentum. The company's low ROE and declining net income, along with shrinking earnings despite retaining all profits, suggest potential issues with its business operations or capital allocation.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
Translate
Report
8333 Views
Comment
Sign in to post a comment